Image: The Times

The Central Government Panel recommended 12-16 week gap for the Doses of Covishield Vaccine which is produced from the Serum Institute of India (SSI) Pune. The Increase in the demand of the vaccine in India are making the manufactures to face the trouble of supplying the vaccinations to every state in the country on time. The patients in India are at the peak with large number of deaths due to the lack of medical facilities after the collapse of the medical infrastructure due to the overload of patients in the hospitals and camps. The Inventors of Covishield Vaccine are facing Vaccine shortage complaints from many states in India

Image: Mint

CEO of the Serum Institute of India (SSI) Adar Poonawalla said that “this is beneficial both from the efficacy and the immunogenicity standpoint,”

Image: News On AIR
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Jammu And Kashmir Government Announced Summer Vacation For Jammu Division students from June 8 to July 25, 2021

Jammu and Kashmir Government Announced Summer Vacation For The Students From June 8 July 25, 2021

India 🇮🇳 Hits With NewBie COVID-19 Variant, The Delta Plus

India To Face The COVID-19 Infection Calamity With The New Delta Plus Variant Soon

Apply For Travel E-pass Online Through the Mode Of Internet From May 15, 2021 Evening In Kerala

Apply For The Travel E-Pass Through The Jagratha Portal By The Kerala state Government

Forty Labs In Karnataka Labs Fined With ₹ 20 Lakh For Delaying The COVID-19 Test Reports

Karnataka Labs Fined With ₹20 Lakh For Delaying The Covid Report